MARKET

VRNA

Verona Pharma
VRNA
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-50.2680
213.99
40.17
9,247,272,606.42
Edgewise Therapeutics Appoints Christopher Martin to Board of Directors
Reuters · 11/20 13:00
Ligand Pharma Q3 revenue jumps; raises 2025 guidance
Reuters · 11/06 12:12
Merck Reports Third-Quarter Sales of $17.3 Billion
Reuters · 10/30 10:31
*News On Verona Pharma PLC (VRNA) Now Under MRK
Dow Jones · 10/07 21:08
VRNA Quantitative Stock Analysis
NASDAQ · 10/07 20:04
Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?
NASDAQ · 10/07 12:27
Verona Pharma Completes Acquisition and Delisting Process
TipRanks · 10/07 11:29
Merck Completes Acquisition of Verona Pharma, Adding COPD Drug Ohtuvayre to Portfolio
Reuters · 10/07 10:45
More

Webull offers Verona Pharma stock information, including NASDAQ: VRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRNA stock methods without spending real money on the virtual paper trading platform.